Cupferron

Cupferron

SCHEMBL451471

O=NN(O)c1ccccc1.[AlH3]

nearest known ligand 0.54

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.54
ALOX15 P16050 1/20 0.54
NPSR1 Q6W5P4 2/20 0.42
HSP90AA1 P07900 1/20 0.36
ESR1 P03372 1/20 0.36
KMT2A Q03164 3/20 0.36
HTT P42858 2/20 0.36
MEN1 O00255 2/20 0.36
NPC1 O15118 1/20 0.35
POLB P06746 1/20 0.35
RAB9A P51151 1/20 0.35
GLA P06280 1/20 0.35
TSHR P16473 1/20 0.35
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
L3MBTL1 Q9Y468 2/20 0.34
ATM Q13315 1/20 0.34
TDP1 Q9NUW8 1/20 0.34
PKM P14618 1/20 0.34
GAA P10253 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cupferron SCHEMBL29005356 1.00 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL471987 1.00 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL8588885 0.98 ALDH1A1 (0.52) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL37151 0.97 ALDH1A1 (0.56) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL7506189 0.95 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL7513315 0.95 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL21670426 0.95 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL21670430 0.95 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL52291 0.95 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1
Cupferron SCHEMBL1719170 0.95 ALDH1A1 (0.54) ALDH1A1ALOX15NPSR1HSP90AA1ESR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1420 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12603202-B2 Method for manufacturing sintered magnet and sintered magnet NINGBO KONIT INDUSTRIES INC. (CN) 2026-04-14 US claimed
CN-119684837-A Preparation method of photo-curing flexographic printing ink for outdoor reflective film 浙江龙游道明光学有限公司 2025-03-25 CN claimed
US-20250026917-A1 ULTRAVIOLET-CURABLE RESIN COMPOSITION, ADHESIVE, SEALANT, INSULATING PROTECTIVE AGENT, AND ELECTRONIC CIRCUIT BOARD PELNOX, LTD. (JP) 2025-01-23 US claimed
US-20240290522-A1 Method for Manufacturing Sintered Magnet and Sintered Magnet NINGBO HEFENG NEW MATERIAL CO.,LTD (CN) 2024-08-29 US claimed
CN-117916289-A Ultraviolet-curable resin composition, adhesive, sealant, insulation protector, and electronic circuit board 荒川化学工业株式会社 2024-04-19 CN claimed
CN-117916290-A Ultraviolet-curable resin composition, adhesive, sealant, insulation protective agent, and electronic circuit board 荒川化学工业株式会社 2024-04-19 CN claimed
CN-117659913-A Glue composition for quantum dots 益丰新材料股份有限公司 2024-03-08 CN claimed
CN-117039142-A Composite solid electrolyte and preparation method and application thereof 楚能新能源股份有限公司 2023-11-10 CN claimed
EP-3694842-B1 PROCESS FOR PREPARING 2,5-FURANDICARBOXYLIC ACID SYNPHABASE AG (CH) 2023-01-25 EP claimed
US-11421063-B2 Preformed stabilizers with improved stability COVESTRO LLC (US) 2022-08-23 US claimed
CN-111194311-A Process for the preparation of furan-2, 5-dicarboxylic acid 辛法贝斯股份公司 2020-05-22 CN claimed
WO-2020040052-A1 CURABLE RESIN COMPOSITION AND CURED PRODUCT THEREFROM 昭和電工株式会社 2020-02-27 WO claimed
EP-3423900-A1 METHOD OF IMPROVING LIGHT STABILITY OF FLEXOGRAPHIC PRINTING PLATES FEATURING FLAT TOP DOTS Macdermid Graphics Solutions, LLC (US) 2019-01-09 EP claimed
US-10108087-B2 Method of improving light stability of flexographic printing plates featuring flat top dots MACDERMID GRAPHICS SOLUTIONS LLC (US) 2018-10-23 US claimed
US-20170259607-A1 Method of Improving Light Stability of Flexographic Printing Plates Featuring Flat Top Dots MACDERMID GRAPHICS SOLUTIONS, LLC 2017-09-14 US claimed
EP-2835365-A1 A process to produce N-ethenyl-N-alkyl-alkylamides S.P.C.M. SA (FR) 2015-02-11 EP claimed
US-8389593-B2 Composition for simultaneously forming two isolated column spacer patterns LG CHEM, LTD. (KR) 2013-03-05 US claimed
US-20100160477-A1 Composition for simultaneously forming two isolated column spacer patterns LG CHEM, LTD. (KR) 2010-06-24 US claimed
US-5876805-A CONTAINING FREE RADICAL POLYMERIZABLE UNSATURATED COMPOUNDS MINNESOTA MINING & MANUFACTURING CO. (US) 1999-03-02 US claimed
US-4275142-A CONJUGATED DIOLEFIN-ACRYLIC ACID OR ANHYDRIDE COPOLYMER, PHOTOSENSITIZER JAPAN SYNTHETIC RUBBER CO., LTD. (JP) 1981-06-23 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12603202-B2 Method for manufacturing sintered magnet and sintered magnet MTCL3, SUN2, ACTB ALDH1A1 3482/4885ALOX15 4266/4885NPSR1 4613/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.